Farther Finance Advisors, LLC Cytom X Therapeutics, Inc. Transaction History
Farther Finance Advisors, LLC
- $9.33 Trillion
- Q4 2025
A detailed history of Farther Finance Advisors, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 7,875 shares of CTMX stock, worth $30,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,875
Previous 7,970
1.19%
Holding current value
$30,397
Previous $25.4 Million
31.95%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CTMX
# of Institutions
110Shares Held
120MCall Options Held
1.49MPut Options Held
258K-
Vr Adviser, LLC New York, NY15.6MShares$60.1 Million7.54% of portfolio
-
Tang Capital Management LLC San Diego, CA11.1MShares$42.7 Million1.6% of portfolio
-
Perceptive Advisors LLC New York, NY9.68MShares$37.4 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$34.5 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA8.46MShares$32.7 Million0.92% of portfolio
About CytomX Therapeutics, Inc.
- Ticker CTMX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,950,200
- Market Cap $255M
- Description
- CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...